# lf0: Quantitative Research Desk

> Systematic, evidence-led quantitative research for serious investors. Equity analysis, backtesting, and strategy research from lf0.

lf0 publishes independent quantitative research on individual equities and systematic trading strategies. All content is research and educational commentary only — not investment advice. Research is generated using a combination of SEC filings, Yahoo Finance financial data, and LLM-assisted analysis.

## About lf0

- [About](https://lf0.com/about/): Who we are and our approach to quantitative research.
- [Contact](https://lf0.com/contact/): Get in touch with the research team.
- [Subscribe](https://lf0.com/subscribe/): Get free research notes delivered by email.
- [Risk Disclaimer](https://lf0.com/risk-disclaimer/): Full risk disclosure for all lf0 research content.
- [Privacy Policy](https://lf0.com/privacy/): Privacy policy for lf0.com.

## Research Series

- [Equity Research](https://lf0.com/research-series/equity-research/): In-depth equity research reports on individual companies. Covers financial performance (revenue, EBIT, margins, leverage), comparable company analysis, competitive positioning, risk factors from 10-K filings, and forward-looking investment thesis. Built from Yahoo Finance data and SEC filings.
- [Backtesting Strategies](https://lf0.com/research-series/backtesting-strategies/): Systematic quantitative trading strategies backtested with historical market data. Covers momentum, mean reversion, and hybrid rule-based approaches across US equities and ETFs. Includes signal logic, performance attribution, and regime analysis.
- [Quant Report](https://lf0.com/research-series/quant-report/): Quantitative market research covering factor analysis, strategy screens, and systematic signal generation for US equities and sector ETFs.
- [SEC What Changed](https://lf0.com/research-series/sec-what-changed/): Daily AI-assisted monitoring of SEC 10-K annual report filings. Ranks and summarises language changes across risk factors, business descriptions, and management discussion sections for companies filing on a given date.

## Equity Research

- [Abbott Laboratories Stock Analysis (ABT)](https://lf0.com/research/abbott-laboratories-stock-analysis-abt/): Abbott Laboratories (ABT) is rated Hold as its diversified healthcare platform supports stability, but valuation and execution concerns cap near-term upside. Q1 2026 revenue and EBIT weakened sequentially, while debt tied to acquisition financing could pressure flexibility.
- [Atlassian Stock Analysis (TEAM)](https://lf0.com/research/atlassian-stock-analysis-team/): Atlassian (TEAM) earns a HOLD rating as its subscription software base and strong cash generation offset weak profitability. The key question is whether cloud migration and operating leverage can turn 3.6x EV/revenue into durable earnings power.
- [Boston Scientific Stock Analysis (BSX)](https://lf0.com/research/boston-scientific-stock-analysis-bsx/): Boston Scientific (BSX) earns a Buy rating on double-digit revenue growth, expanding EBITDA, and improving free cash flow. The key question is whether management can sustain execution while navigating reimbursement pressure and acquisition-led capital deployment.
- [Celsius Holdings Stock Analysis (CELH)](https://lf0.com/research/celsius-holdings-stock-analysis-celh/): Celsius Holdings (CELH) is rated HOLD as strong revenue growth, free cash flow, and a rebound in EBITDA are offset by heavy Pepsi dependence. The stock looks reasonably valued, but concentration risk remains the main overhang.
- [General Electric Stock Analysis (GE)](https://lf0.com/research/general-electric-stock-analysis-ge/): General Electric (GE) earns a HOLD rating as strong margins and cash generation are offset by a premium valuation. The 40.4x trailing P/E and 31.4x EV/EBITDA leave little room for execution misses.
- [Intuitive Surgical Stock Analysis (ISRG)](https://lf0.com/research/intuitive-surgical-stock-analysis-isrg/): Intuitive Surgical (ISRG) earns a HOLD rating as its dominant installed base and recurring revenue support strong cash generation, but the stock already prices in durable execution at a rich valuation, with China tender delays clouding near-term upside.
- [LyondellBasell Stock Analysis (LYB)](https://lf0.com/research/lyondellbasell-stock-analysis-lyb/): LyondellBasell Industries N.V. (LYB) is rated Hold as valuation looks reasonable, but the stock still depends on a durable margin recovery rather than structural growth amid persistent chemical oversupply.
- [Sky Harbour Stock Analysis (SKYH)](https://lf0.com/research/sky-harbour-stock-analysis-skyh/): Sky Harbour Group Corp. (SKYH) earns a SELL rating as its valuation already prices in a successful lease-up while profitability and cash generation remain weak. $555.9M of debt and negative levered free cash flow make execution and refinancing the key risks.
- [SoundHound AI Stock Analysis (SOUN)](https://lf0.com/research/soundhound-ai-stock-analysis-soun/): SoundHound AI (SOUN) is rated SELL as rapid revenue growth is offset by weak profitability and ongoing cash burn — TTM operating cash flow was -$105.3M, leaving little room for error.
- [Symbotic Stock Analysis (SYM)](https://lf0.com/research/symbotic-stock-analysis-sym/): Symbotic (SYM) is rated Hold as revenue growth stays strong but profitability remains early. TTM operating margin was flat and customer concentration is high, even as deployment-driven growth continues.
- [Teradyne Stock Analysis (TER)](https://lf0.com/research/teradyne-stock-analysis-ter/): Teradyne (TER) is rated HOLD as strong AI-driven growth and operating leverage are already offset by a steep valuation. Q1 2026 revenue rose 87% year over year, but customer concentration and rich multiples limit upside.
- [UiPath Stock Analysis (PATH)](https://lf0.com/research/uipath-stock-analysis-path/): UiPath (PATH) earns a HOLD rating as its valuation already reflects a better monetization and margin story. ARR growth slowed to 11% and dollar-based net retention slipped to 107%.
- [Utility Income Fund Stock Analysis (UTF)](https://lf0.com/research/utility-income-fund-stock-analysis-utf/): Utility Income Fund (UTF) earns a HOLD rating as its 6.8x trailing P/E and strong operating margin are offset by weak cash generation and tight liquidity.
- [Verizon Stock Analysis (VZ)](https://lf0.com/research/verizon-stock-analysis-vz/): Verizon Communications Inc. (VZ) earns a HOLD rating as its defensive cash flow and 7.5x EV/EBITDA valuation are offset by heavy leverage — $200.9B of debt keeps refinancing risk front and center.
- [Willdan Group Stock Analysis (WLDN)](https://lf0.com/research/willdan-group-stock-analysis-wldn/): Willdan Group, Inc. (WLDN) earns a HOLD rating as solid procurement access and a clean balance sheet are offset by a rich valuation — 23.9x EV/EBITDA against only 4.7% operating margin.

## Backtesting Strategies

- [PBands Lower Band Mean Reversion Long Only — XLP Backtesting Analysis](https://lf0.com/research/backtests/backtesting-strat-pbands-mean-reversion-long-only-xlp/): Backtests a Percentage Bands mean-reversion strategy on XLP (Consumer Staples Select Sector SPDR), 2016–2020, using quantstrat (R). Buys when price crosses below the lower Percentage Band; exits at the center line or a 5% trailing stop. Net P&L: $703 on $100,000; CAGR 0.18%; Sharpe 6.87; profit factor 2.76; 15 trades; max drawdown -0.28%. Edge is structurally plausible but too infrequent to be trade-ready without refinement.

## Quant Report — Strategy Selection Screens

- [XLP: Momentum, Mean Reversion, or No Trade?](https://lf0.com/research/quant-research/xlp-etf-momentum-mean-reversion-strategy-analysis/): Strategy-selection screen for XLP (Consumer Staples Select Sector SPDR), sample window 2023–2024. Autocorrelation, ARIMA, and GARCH tests converge on near-randomness in XLP returns at daily frequency. No standalone momentum or mean-reversion edge found; risk controls are the practical takeaway.
- [NVDA: Momentum, Mean Reversion, or No Trade?](https://lf0.com/research/quant-research/nvda-stock-momentum-mean-reversion-strategy-analysis/): Strategy-selection screen for NVDA (NVIDIA Corp), sample window 2023–2024. Descriptive, distribution, autocorrelation, and model-confirmation tests indicate no durable edge. Tail risk behavior and return distribution shape should drive strategy design.
- [SPY: Momentum, Mean Reversion, or No Trade?](https://lf0.com/research/quant-research/spy-etf-momentum-mean-reversion-strategy-analysis/): Strategy-selection screen for SPY (S&P 500 ETF Trust), sample window 2023–2024. No strong momentum or mean-reversion signal confirmed; analysis reached maximum step count before finalizing. Risk controls and regime filtering recommended as next steps.
- [XLF: Momentum, Mean Reversion, or No Trade?](https://lf0.com/research/quant-research/xlf-etf-momentum-mean-reversion-strategy-analysis/): Strategy-selection screen for XLF (Financial Select Sector SPDR), sample window 2023–2024. ARIMA and ARFIMA find no mean-reversion pattern; residual volatility is only partially captured. No standalone directional edge identified.

## SEC What Changed — 10-K Filing Snapshots

- [SEC What Changed: 10-K Filing Snapshot for 5 June 2026](https://lf0.com/quantitative-research/sec-what-changed-2026-06-05/): Four companies filed 10-K annual reports on 5 June 2026; all four had prior-year comparisons. Sentinel Holdings Ltd. (Risk Factors cosine similarity 0.764) and NetApp, Inc. (0.796) showed the most significant disclosure language changes; both flagged high significance.
- [SEC What Changed: 10-K Filing Snapshot for 4 June 2026](https://lf0.com/quantitative-research/sec-what-changed-2026-06-04/): Four companies filed on 4 June 2026. World Acceptance Corp (Risk Factors similarity 0.08 — near-complete rewrite) and Orion Energy Systems (0.084) showed dramatic risk disclosure rewrites. La Rosa Holdings Corp showed significant business description changes (similarity 0.719).
- [SEC What Changed: 10-K Filing Snapshot for 3 June 2026](https://lf0.com/quantitative-research/sec-what-changed-2026-06-03/): Three companies filed on 3 June 2026; all had prior-year comparisons. Mesa Laboratories ranked #1 with a Business section similarity of 0.974. A relatively quiet filing day — no high-significance disclosures; all filings showed similarities above 0.97.
- [SEC What Changed: 10-K Filing Snapshot for 2 June 2026](https://lf0.com/quantitative-research/sec-what-changed-2026-06-02/): Seven companies filed on 2 June 2026; five had prior-year comparisons. UPAY showed substantial rewrites in both Business (similarity 0.565) and Risk Factors (0.565) — the most significant change in the batch. INVO Fertility Risk Factors also flagged high. Two filers (PetMed Express, HIVE Digital) excluded for lack of prior-year comparison.
- [SEC What Changed: 10-K Filing Snapshot for 1 June 2026](https://lf0.com/research/sec-what-changed-2026-06-01/): Five companies filed on 1 June 2026. ProPhase Labs eliminated its entire Risk Factors section (invoking a smaller reporting company exemption, replacing ~30 pages with one sentence) and repositioned its business from COVID diagnostics to genomics and biopharma (Nebula Genomics, ProPhase BioPharma, BE-Smart esophageal test with Mayo Clinic).

## All Research

- [All Research](https://lf0.com/category/research/): Full archive of all published quantitative research.
- [Equity Coverage](https://lf0.com/asset-class/equity/): Individual equity research reports.
- [ETF Coverage](https://lf0.com/asset-class/etf/): ETF and index-level strategy research.

## Optional

- [Sitemap index](https://lf0.com/sitemap_index.xml)